Abstract
Chagas disease (CHD) is a highly debilitating disease and affects around 1.2 million people in Brazil. Chronic chagasic cardiopathy (CCC) is the most severe clinical disease manifestation and affects 30% of patients, while 60% remain in the indeterminate form. There are no biomarkers of classification of the clinical forms and prognostic of progression to CCC, and these are urgently neede…